Risk factors contributing to LBP worldwide have shifted between 1990 and 2021, with high BMI increasingly impacting years lived with disability due to LBP.

A recent preclinical study led by researchers at McGill University has identified two promising drug candidates—o-Vanillin ...

Dr. Natalia Serrano, Senior Associate Director Global Medical Affairs at Bayer, the maker of Aleve, shares the latest ...

Doing crunches is a great way to build your core strength, but that can only happen if you're doing them correctly. Here, a ...

Vanillin and RG-7112—can clear “zombie cells” from spinal discs, potentially treating the root cause of chronic low back pain ...

In conjunction with the event, Aclarion has published its updated investor presentation, which can be found on its website at ...

ASML Q1 earnings were respectable, but Q2 guidance indicates a sharp slowdown in revenue growth. Read why ASML stock is ...

In a preclinical study, two drugs targeting 'zombie cells' have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. Current ...

Considering the average person in the spends around 2,000 hours at work every year, many people are using biohacking ...

Kegels can actually make pelvic floor dysfunction worse if the issue is muscle tightness or poor coordination rather than ...

The 20-DMA continues to act as overhead resistance, defining the current downtrend. While there is undoubtedly a risk of ...

Every prescription and medical report I receive now goes through ChatGPT. I can say with confidence that if ChatGPT were ...